British Journal of Cancer

Published by: Nature Publishing Group  

People

  1. Lilja
    Lilja
  2. Offit
    Offit
  3. Pike
    Pike
  4. Vickers
    Vickers
  5. Bernstein
    Bernstein
  6. Jones
    Jones
  7. Olson
    Olson
  8. Scardino
    Scardino
  9. Begg
    Begg
  10. Joseph
    Joseph

Groups

  1. Population Sciences Research Program (41)
  2. Epidemiology and Biostatistics (24)
  3. Survivorship Research (23)
  4. Department of Medicine (15)
  5. Epidemiology Service (15)
  6. Solid Tumor Oncology Division (15)
  7. Surgery (12)
  8. Health Outcomes Research Group (11)
  9. Urology (10)
  10. Clinical Genetics Service (8)
Search Within
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (39)
  2. Meeting Abstract (1)
  3. Review (1)
Groups
  1. Population Sciences Research Program (41)
  2. Epidemiology and Biostatistics (24)
  3. Survivorship Research (23)
  4. Department of Medicine (15)
  5. Epidemiology Service (15)
  6. Solid Tumor Oncology Division (15)

More Groups

People
  1. Hans Lilja (8)
  2. Kenneth Offit (8)
  3. Malcolm Pike (7)
  4. Andrew Vickers (6)
  5. Jonine Bernstein (4)
  6. Lee Jones (4)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (3)
  5. 2020 (1)
  6. 2019 (2)

More Years

Publishers
  1. Nature Publishing Group (41)

Results (41)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-diagnosis tea and coffee consumption and survival after a diagnosis of ovarian cancer: Results from the Ovarian Cancer Association Consortium
    Journal Article

    Nagle, C. M.; Ibiebele, T. I.; Bandera, E. V.; Cramer, D.; Doherty, J. A.; Giles, G. G.; Goodman, M. T.; Hanley, G. E.; Harris, H. R.; Jensen, A.; more...
    British Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
    Journal Article

    O’Mahony, D. G.; Ramus, S. J.; Southey, M. C.; Meagher, N. S.; Hadjisavvas, A.; John, E. M.; Hamann, U.; Imyanitov, E. N.; Andrulis, I. L.; Sharma, P.; more...
    British Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Associations between circulating proteins and risk of breast cancer by intrinsic subtypes: A Mendelian randomisation analysis
    Journal Article

    Shu, X.; Zhou, Q.; Sun, X.; Flesaker, M.; Guo, X.; Long, J.; Robson, M. E.; Shu, X. O.; Zheng, W.; Bernstein, J. L.
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Association between physical activity and neoadjuvant chemotherapy completion and pathologic complete response in primary breast cancer: The CANTO study
    Journal Article

    Baker, J. L.; Di Meglio, A.; Gbenou, A. S.; El Mouhebb, M.; Iyengar, N. M.; Michiels, S.; Cottu, P.; Lerebours, F.; Coutant, C.; Lesur, A.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence
    Journal Article

    Rasmussen, M.; Fredsøe, J.; Tin, A. L.; Vickers, A. J.; Ulhøi, B.; Borre, M.; Eastham, J.; Ehdaie, B.; Guillonneau, B.; Laudone, V.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Mendelian randomisation study of smoking exposure in relation to breast cancer risk
    Journal Article

    Park, H. A.; Neumeyer, S.; Michailidou, K.; Bolla, M. K.; Wang, Q.; Dennis, J.; Ahearn, T. U.; Andrulis, I. L.; Anton-Culver, H.; Antonenkova, N. N.; more...
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Targeting obesity-related dysfunction in hormonally driven cancers
    Review

    Rubinstein, M. M.; Brown, K. A.; Iyengar, N. M.
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Searching for causal relationships of glioma: A phenome-wide Mendelian randomisation study
    Journal Article

    Saunders, C. N.; Cornish, A. J.; Kinnersley, B.; Law, P. J.; Houlston, R. S.; and Collaborators
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
    Journal Article

    Haese, A.; Tin, A. L.; Carlsson, S. V.; Sjoberg, D. D.; Pehrke, D.; Steuber, T.; Huland, H.; Graefen, M.; Scardino, P. T.; Schlomm, T.; more...
    British Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Interim results from the IMPACT study: Evidence for PSA screening in BRCA2 mutation carriers
    Meeting Abstract

    Page, E.; Bancroft, E.; Brook, M.; Assel, M.; Offman, J.; Kote-Jarai, Z.; Vickers, A.; Lilja, H.; Eeles, R.
    British Journal of Cancer (2019)

    Fulltext@MSK | Save

    • British Journal of Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 Macmillan Publishers Limited
    British Journal of Cancer 0007-0920 Macmillan Publishers Limited
    British Journal of Cancer 00070920 The Author(s) 2024
    British Journal of Cancer 0007-0920 Unknown
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 15321827 Unknown
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 2023, The Author(s), Under Exclusive Licence To Springer Nature Limited
    British Journal of Cancer 15321827 Cancer Research Uk
    British Journal of Cancer 00070920 2022, The Author(s), Under Exclusive Licence To Springer Nature Limited
    British Journal of Cancer 0007-0920 Churchill Livingstone
    British Journal of Cancer 15321827 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 Cancer Research Uk
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 Cancer Research
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 The Author(s)
    British Journal of Cancer 00070920 2019, Cancer Research Uk
    British Journal of Cancer 00070920 2018, Cancer Research Uk
    British Journal of Cancer 00070920 2022, The Author(s)
    British Journal of Cancer 00070920 2023, The Author(s)
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Cancer Research Uk
    British Journal of Cancer 00070920 Cancer Research Campaign
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 The Author(s), Under Exclusive Licence To Springer Nature Limited 2024
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 2021, The Author(s), Under Exclusive Licence To Springer Nature Limited
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 Unknown
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 00070920 2018, The Author(s)
    British Journal of Cancer 0007-0920 Nature Publishing Group
    British Journal of Cancer 0007-0920 Stockton Press
    British Journal of Cancer 0007-0920 Nature Publishing Group
    Unknown (0007-0920) 0007-0920 Unknown